2012 annual financial data

Galectin Therapeutics Inc. 2012 Operating margin

Galectin Therapeutics Inc. 2012 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -9,899,000 USD and net income was -9,675,000 USD.
Operating cash flow was -7,500,000 USD.

Get free Galectin Therapeutics Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-9,899,000 USD
Net income
-9,675,000 USD
Operating cash flow
-7,500,000 USD